Advances in prefilled syringes, connected devices and large-volume injectors continue to shape parenteral drug delivery. This two-day summit focuses on the development of injectable combination products, examining the relationship between device innovation, patient needs and product performance. Quality, safety, human factors and regulatory considerations provide the context for exploring the next generation of injection systems.

Understanding the substances that can migrate from materials into medicines is essential to product safety. This two-day conference focuses on extractables and leachables in pharmaceutical packaging, drug delivery components, medical devices and manufacturing systems, exploring analytical challenges, chemical characterisation and regulatory considerations relevant to evaluating materials and managing potential risks to patients.

Reducing environmental impact presents complex challenges for pharmaceutical packaging and processing, where product protection, quality and patient safety remain essential. This two-day event focuses on sustainability across these interconnected areas, providing a forum for considering how the pharmaceutical industry can balance environmental objectives with the practical demands of packaging development and manufacturing.

Maintaining sterility requires robust processes, effective contamination control and consistent manufacturing practices. This two-day summit focuses on aseptic processing and manufacturing, addressing the challenges associated with producing sterile pharmaceutical products. Its scope encompasses environmental monitoring, cleanroom operations, sterilisation and aseptic process simulation, alongside the technologies and quality considerations supporting reliable sterile production.

Microneedle and transdermal technologies offer alternative approaches to delivering medicines and vaccines through the skin. This two-day forum focuses on the design, formulation and development of skin-mediated delivery systems, exploring the scientific and practical challenges involved in translating promising technologies into products, including materials, manufacturing scale-up, product quality and regulatory considerations.

Developing combination products requires close integration of drug, device and patient needs. This two-day summit focuses on the development, quality and safety of products combining medicines and medical devices. It provides a forum for exploring regulatory considerations, human factors and design challenges, alongside the evolving technologies shaping combination product development and commercialisation.

Extractables and leachables remain a key consideration in the safety and quality of pharmaceutical products. This two-day summit focuses on the analytical, material and regulatory challenges associated with drug packaging, delivery systems and medical devices, providing a forum for examining approaches to chemical characterisation, study design and risk assessment across pharmaceutical and biotechnology applications.